Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of SYMVESS™ in the vascular trauma indication, the development of the product candidates ...
Finji co-founder Bekah Saltsman tells us about the books they love, have loved, and are hoping to love in the future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback